Effects of recombinant platelet activating factor acetylhydrolase in obstructive jaundice

Hepato-Gastroenterology

Volumn 50, Issue 52, 2003, Pages 1097-1100

  Kerek, Mustafa ^a,c   Akyurek, Nusret ^a   Sozuer, Erdogan M ^a   Arar, Makbule ^a   Muhtaroglu, Sabahattin ^b  

^a ERCIYES UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

Anti oxidants; Cytokines; Obstructive jaundice; PAH

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLUTATHIONE PEROXIDASE; ICS 00206; INTERLEUKIN 6; RECOMBINANT PLATELET ACTIVATING FACTOR ACETYLHYDROLASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BLOOD LEVEL; BLOOD SAMPLING; COMMON BILE DUCT; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HISTOPATHOLOGY; INFLAMMATION; LAPAROTOMY; LIVER; LIVER FUNCTION TEST; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; RAT;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; CHOLESTASIS; GLUTATHIONE PEROXIDASE; INTERLEUKIN-6; LIVER FUNCTION TESTS; MALE; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038338598     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Doley JS: Extrahepatic biliary obstruction: systemic effects, diagnosis management. In: Bircher J, Benhamou J-P (eds.). Oxford Textbook of Clinical Hepatology (2nd Edition) Oxford: 1999; pp. 1581-1590.
2. Reilly PM, Schiller HJ, Bulker GB: Pharmacologic approach to tissue injury mediated by free radicals and reactire oxygen metabolites. Am J Surg 1991; 161:488-489.
3. Muriel P, Suarez OR: Role of lipid peroxidation in biliary obstruction in the rat. J Appl Toxicol 1994; 14:423-426.
4. Lechner AJ, Velasquez A, Knudsen KR, Johanns CA, Tracy TF Jr, Matuschak GM: Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia. Am J Respir Crit Care Med 1998; 157:1550-1558.
5. Zhou W, Chao W, Levine BA, Olson MS: Role of platelet-activating factor in hepatic responses after bile duct ligation in rats. Am J Physiol 1992; 263:587-592.
6. Muriel P, Suarez OR, Gonzalez P, Zuñiga L: Protective effect of S-adenosyl-1-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach. J Hepatol 1994; 21:95-102.
7. Parola M, Leonarduzzi G, Robino G, Albano E, Poli G, Dianzani MU: On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radic Biol Med 1996; 20:351-359.
8. Chao W, Liu H, Zhou WD, Hanahan DJ, Olson MS: Regulation of platelet-activating factor receptor and PAF-receptor mediated biological responses by cAMP in rat Kupffer cells. J Biol Chem 1990; 265:17576-17583.
9. Gandhi CR, Hanahan DJ, Olson MS: Two distinct pathway of platelet-activating factor-induced hydrolysis of phoshoinositidites in primary cultures of rat Kupffer cells. J Biol Chem 1990; 265:18234-18241.
10. Chao W, Liu H, Hanahan DJ, Olson MS: Regulation of platelet-activating factor receptor and PAF-receptor mediated arachidonic acid release by protein kinase C activation in rat Kupffer cells. Arch Biochem Biophys 1990; 282:189-197.
11. Cao Y, Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM: Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem 1998; 273:4012-4020.
12. Caplan MS, Lickerman M, Adler L, Dietsch GN, Yu A: The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 1997; 42:779-783.
13. Hofbauer B, Saluja AK, Bhatia M, Frossard JL, Lee HS, Bhagat L, et al: Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterology 1998; 115:1238-247.
14. Castaing D, Houssin D, Bismuth H: Hepatic and portal surgery in rat. Paris: Masson, 1980; pp. 20-38.
15. Matthews, et al: Lymphokines and Interferons, A practical Approach. In: Clemens M, et el. (Eds.). IRL Press, 1987; p. 221.
16. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM: Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987; 17:1411-1416.
17. Van Nieuwkerk CMJ, Oude Elferink RPJ, Groen AK, et al: Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-Glycoprotein gene. Gastroenterology 1996; 111:165-171.
18. Howard KM, Miller JE, Miwa M, Olson MS: Cell-specific regulation of plasma-type platelet-activating factor acetylhydrolase in liver. J Biol Chem 1997; 272:27543-27548.
19. Singh S, Shactleton G, Sing EA, Chakroborty J, Bailey ME: Antioxidant defenses in bile duct-ligated rat. Gastroentrology 1992; 103:1623-1629.
20. Bautista AP, Spitzer JJ: Platelet activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion. Free Radic Res Commun 1992; 17:195-209.
21. Houdijk AP, Boermeester MA, Wesdorp RI, Hack CE, Van Leeuwen PA: Tumor necrosis factor unresponsiveness after surgery in bile duct-ligated rats. Am J Physiol 1996; 271:980-986.
22. Matusckak GM, Henry KA, Johanns CA, Lechner AJ: Liver-Lung interactions following sequental E. coli bacteremia and hepatic ischemia/reperfusion. Crit Care Med 1997; 25:27-31.